ANXA2 and hepatocellular carcinoma: ANXA2 was found to have higher expression levels in HCC tissues than that in matched peritumoral tissues, and this higher expression level of ANXA2 represented a shorter tumor-free survival period in the Kaplan-Meyer analysis.